search
Back to results

NMES Efficacy on Patients With NBPP

Primary Purpose

Neonatal Brachial Plexus Palsy

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Standard NMES device
Sham NMES device
Sponsored by
University of Michigan
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Neonatal Brachial Plexus Palsy focused on measuring Brachial plexus injury, Brachial plexus palsy, Neonate

Eligibility Criteria

3 Months - 9 Months (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Children ages 3-9 months at time of enrollment
  • NBPP patients who receive care from University Of Michigan Brachial Plexus Palsy clinic
  • All gender/race/financial backgrounds
  • active range of motion (AROM) elbow flexion <150°
  • All Narakas grades
  • British Medical Research Council (MRC) grade 2- or 4 for biceps brachii

Exclusion Criteria:

  • Brachial Plexus patients require needing surgical repair
  • Patients with any existing secondary medical conditions
  • Patients with elbow contracture greater than 5°
  • British Medical Research Council (MRC) grade 5 for biceps brachii
  • active range of motion (AROM) elbow flexion =150°
  • Non-English speaking families
  • Children already using NMES unit

Sites / Locations

  • University of Michigan

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Sham Comparator

Arm Label

Standard NMES cohort

Sham NMES cohort

Arm Description

Patients who will apply standard NMES device.

Patients who will apply sham NMES device.

Outcomes

Primary Outcome Measures

Change From Baseline in Upper Extremity Muscle Strength
One of the two-blinded occupational therapists will conduct the evaluation at enrollment and 3-month follow-up clinic visit. In this study, we will evaluate the biceps strength using the British Medical Research Council (MRC) grading system. The British Medical Research Council (MRC) grading system for muscle strength is based on a scale from 0 (minimum score, not testable), 1, 2, 3, 4, to 5 (maximum score, normal strength); higher score means better outcome. British Medical Research Council (MRC) grade 2 or higher is functional in terms of muscle power. In current study, we will examine the change of biceps British Medical Research Council (MRC) grade from baseline to 3-month.
Change From Baseline in Upper Extremity Range of Motion
One of the two-blinded occupational therapists will assess the active range of motion (AROM) of elbow flexion using goniometer at enrollment and 3-month follow-up clinic visit. The minimum degree is 0 and the maximum degree is 150; the higher degree means better outcome. We will then examine the change of elbow flexion active range of motion (AROM) from baseline to 3-month.

Secondary Outcome Measures

Full Information

First Posted
October 29, 2013
Last Updated
December 12, 2018
Sponsor
University of Michigan
Collaborators
Spring Arbor University
search

1. Study Identification

Unique Protocol Identification Number
NCT01999465
Brief Title
NMES Efficacy on Patients With NBPP
Official Title
Neuromuscular Electrical Stimulation (NMES) Efficacy on Patients With Neonatal Brachial Plexus Palsy (NBPP)
Study Type
Interventional

2. Study Status

Record Verification Date
December 2018
Overall Recruitment Status
Completed
Study Start Date
November 2013 (Actual)
Primary Completion Date
January 31, 2018 (Actual)
Study Completion Date
January 31, 2018 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Michigan
Collaborators
Spring Arbor University

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Neonatal Brachial Plexus Palsy (NBPP), characterized by weakness and sensory loss in the affected arm, results from damage in the prenatal period to the nerves extending from the spine to the arm. Proper stretching and exercise of the joints and affected arm from the time of diagnosis can greatly assist in the development of healthy movement of the limb. Additionally, neuromuscular electrical stimulation has been shown to be an effective treatment in other neural disorders and therefore its effectiveness in NBPP is worth studying. In the case of NBPP patients, the loss in normal arm function can be observed very early. Young patients will often neglect using the affected arm or modify motions to avoid the use of the biceps muscle, specifically in hand to mouth actions such as gripping a bottle or placing toys or other objects in the mouth. A goal of this study is to test the effectiveness of NMES on improving the biceps muscle Medical Research Council (MRC) strength and active range of motion (AROM). The subjects of this study are newborns between the ages of 3-9 months who are already a part of the University of Michigan Brachial Plexus program. Parents of the children will be trained to perform the neuromuscular electrical stimulation therapy at home using the EMPI Continuum unit for 30 minutes each day and monthly follow up appointments will be performed be the research occupational therapists throughout three month study period. Parents of the participants will complete a questionnaire before and during the study period to help analyze for confounders and gather data regarding parent compliance and NMES effectiveness. To detect the effectiveness of NMES, two cohort groups using standard units and sham units will be recruited and compare with data analysis. The investigators predict that the NMES will effectively improve the ability of the neonate to increase use of the affected arm, specifically in muscle strength biceps MRC score and AROM.
Detailed Description
The purpose of this study is to investigate whether the use of Neuromuscular Electrical Stimulation (NMES), via the Empi® Continuum unit, will improve the ability with which children with Neonatal Brachial Plexus Palsy (NBPP) are able to use their biceps muscle in activities of daily living. We will examine the British Medical Research Council (MRC) muscle strength and participants' ability to perform active range of motion (AROM) movements. Patients will be divided into two groups with one group receiving NMES and the other receiving sham NMES. We plan to analyze the effects of this one treatment intervention of NMES to determine if the device improves the function of the biceps muscle strength and motion.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Neonatal Brachial Plexus Palsy
Keywords
Brachial plexus injury, Brachial plexus palsy, Neonate

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderOutcomes Assessor
Allocation
Randomized
Enrollment
20 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Standard NMES cohort
Arm Type
Active Comparator
Arm Description
Patients who will apply standard NMES device.
Arm Title
Sham NMES cohort
Arm Type
Sham Comparator
Arm Description
Patients who will apply sham NMES device.
Intervention Type
Device
Intervention Name(s)
Standard NMES device
Other Intervention Name(s)
Neuromuscular electrical stimulation (NMES)
Intervention Description
Blinded parents will follow the NMES parent instructions and place the NMES on the biceps muscle of their child for 30 minutes every day for three months. Rate(35 Hz) Width (300 us) Ch1 Ramp+ (2 seconds) On Time 1 (10 seconds) Ch1 Ramp - (2 seconds)
Intervention Type
Device
Intervention Name(s)
Sham NMES device
Intervention Description
Blinded parents will follow the NMES parent instructions and place the NMES on the biceps muscle of their child for 30 minutes every day for three months. Rate(35 Hz) Width (48 us) Ch1 Ramp+ (0 seconds) On Time 1 (0 seconds) Ch1 Ramp - (0 seconds)
Primary Outcome Measure Information:
Title
Change From Baseline in Upper Extremity Muscle Strength
Description
One of the two-blinded occupational therapists will conduct the evaluation at enrollment and 3-month follow-up clinic visit. In this study, we will evaluate the biceps strength using the British Medical Research Council (MRC) grading system. The British Medical Research Council (MRC) grading system for muscle strength is based on a scale from 0 (minimum score, not testable), 1, 2, 3, 4, to 5 (maximum score, normal strength); higher score means better outcome. British Medical Research Council (MRC) grade 2 or higher is functional in terms of muscle power. In current study, we will examine the change of biceps British Medical Research Council (MRC) grade from baseline to 3-month.
Time Frame
Baseline to 3-month.
Title
Change From Baseline in Upper Extremity Range of Motion
Description
One of the two-blinded occupational therapists will assess the active range of motion (AROM) of elbow flexion using goniometer at enrollment and 3-month follow-up clinic visit. The minimum degree is 0 and the maximum degree is 150; the higher degree means better outcome. We will then examine the change of elbow flexion active range of motion (AROM) from baseline to 3-month.
Time Frame
Baseline to 3-month.
Other Pre-specified Outcome Measures:
Title
Change From Baseline in Spontaneous Hand-to-Mouth Movement
Description
Study coordinators will conduct one-minute video recording with patient in supported sitting position in a chair or seated on parents lap at initial and monthly clinic visits. A toy, pacifier, or bottle will be provided to trigger patient's spontaneous hand-to-mouth movement. The frequency of hand to mouth motion will be recorded and separated out as to the positioning of the elbow. We are evaluating the motion to determine if the motion of the elbow flexion is against gravity, (the arm held at the side of the body or in an adducted position) or in gravity-eliminated position, (the arm held away from the body or in an abducted position). We are looking at the strength of the biceps in its ability to lift the arm against gravity during functional hand to mouth activities. The NMES unit will not be in use during the videotaping process; we are looking at the spontaneous movement of the extremity.
Time Frame
Baseline to 3-month.
Title
Change From Baseline in Participant's Current Therapy
Description
Parents will complete a survey asking participant's current therapy program, including therapy type, setting, frequency, duration, other treatment activities, splint usage, home range of motion exercise program and its frequency and duration at initial and monthly follow-up visits. The purpose of this survey is to help us understand whether there are potential confounders that could affect the study result.
Time Frame
Baseline to 3-month.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
3 Months
Maximum Age & Unit of Time
9 Months
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Children ages 3-9 months at time of enrollment NBPP patients who receive care from University Of Michigan Brachial Plexus Palsy clinic All gender/race/financial backgrounds active range of motion (AROM) elbow flexion <150° All Narakas grades British Medical Research Council (MRC) grade 2- or 4 for biceps brachii Exclusion Criteria: Brachial Plexus patients require needing surgical repair Patients with any existing secondary medical conditions Patients with elbow contracture greater than 5° British Medical Research Council (MRC) grade 5 for biceps brachii active range of motion (AROM) elbow flexion =150° Non-English speaking families Children already using NMES unit
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Lynda Yang, MD, PhD
Organizational Affiliation
Neurosurgery Department, University of Michigan Health System
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Michigan
City
Ann Arbor
State/Province
Michigan
ZIP/Postal Code
48109
Country
United States

12. IPD Sharing Statement

Learn more about this trial

NMES Efficacy on Patients With NBPP

We'll reach out to this number within 24 hrs